Antidiabetic effects of extracts from Psidium guajava

Journal of Ethnopharmacology

Volumn 96, Issue 3, 2005, Pages 411-415

  Oh, Won Keun ^a   Lee, Chul Ho ^a   Lee, Myung Sun ^a   Bae, Eun Young ^a   Sohn, Cheon Bae ^b   Oh, Hyuncheol ^a   Kim, Bo Yeon ^a   Ahn, Jong Seog ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Blood glucose; Leprdb Leprdb mice; Psidium guajava; PTP1B; Type 2 diabetes

Indexed keywords

FAT DROPLET; GLUCOSE; PLANT EXTRACT; PROTEIN TYROSINE PHOSPHATASE 1B; ANTIDIABETIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GUAVA; LIVER HISTOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; AGE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; FATTY LIVER; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE MUTANT; PATHOLOGY; PHYTOTHERAPY;

ANIMALIA; MYRTACEAE; PSIDIUM GUAJAVA;

AGE FACTORS; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PSIDIUM;

EID: 21644468952     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.09.041     Document Type: Article

References (24)

1. Aguilar, A., Argueta, A., Cano, L., 1994. Flora medicinal indígena de Mexico. Treinta y cinco monografías del Atlas de las Plantas de la Medicina Tradicional Mexicana, vol. 2. IXI, Mexico, p. 45.
2. Begum, S., Hassan, S.I., Siddiqui, B.S., Shaheen, F., Ghayur, M.N., Gilani, A.H., 2002. Triterpenoids from the leaves of Psidium guajava. Phytochemistry 61, 399-403.
3. Burke, T.R., Ye, B., Yan, X., Wang, S., Jia, Z., Chen, L., Zhang, Z.-Y., Barford, D., 1996. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design. Biochemistry 35, 15989-15996.
4. Cheng, J.T., Yang, R.S., 1983. Hypoglycemic effect of guava juice in mice and human subjects. American Journal of Chinese Medicine 11, 74-76.
5. Cheung, A., Kusari, J., Jansen, D., Bandyopadhyay, D., Kusari, A., Bryer-Ash, M., 1999. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. Journal of Laboratory and Clinical Medicine 134, 115-123.
6. Dadke, S., Chernoff, J., 2003. Protein-tyrosine phosphatase 1b as a potential drug target for obesity. Current drug targets. Immune, endocrine and metabolic disorders. 3, 299-304.
7. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A.L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., Ramachandran, C., Gresser, M.J., Trmblay, M.L., Kennedy, B.P., 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548.
8. Hamaguchi, T., Sudo, T., Osada, H., 1995. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Letters 372, 54-58.
9. Hong, J.H., Lee, M.S., Bae, E.Y., Kim, Y.H., Oh, H., Oh, W.K., Kim, B.Y., Ahn, J.S., 2004. Screening for the inhibitory activity of medicinal plants against protein tyrosine phosphatase 1B. Korean Journal of Pharmacognosy 35, 16-21.
10. Johnson, T.O., Ermolieff, J., Jirousek, M.R., 2002. Protein tyrosine phosphatase 1b inhibitors for diabetes. Nature Review Drug Discovery 1, 696-709.
11. Kim, J.K., Fillmore, J.J., Chen, Y., Yu, C., Moore, I.K., Pypaert, M., Lutz, E.P., Kako, Y., Velez-Carrasco, W., Goldberg, I.J., Breslow, J.L., Shulman, G.I., 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 98, 7522-7577.
12. Klaman, L.D., Boss, O., Peroni, O.D., Kim, J.K., Martino, J.L., Zabolotny, J.M., Moghal, N., Lubkin, M., Kim, YB., Sharpe, A.M., Stricker-Krongrad, A., Shulman, G.I., Neel, B.C., Kahn, B.B., 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and Cellular Biology 20, 5479-5489.
13. Lozoya, X., About-Zaid, M.N., Nozzilillo, C., Arnason, J.T., 1990. Spasmolytic effect of the methanolic extract of Psidium guajava. Planta Medica 56, 686-689.
14. Lozoya, X., Meckes, M., Abou-Zaid, M., Tortoriello, J., Nozzolillo, C., Arnason, J.T., 1994. Quercetin glycosides in Psidium guajava L. leaves and determination of a spasmolytic principle. Archives of Medical Research 25, 11-15.
15. Lozoya, X., 1999. Xiuhpatli. In: Herba Officinalis. SSA/UNAM, Mexico, p. 127.
16. Lozoya, X., Reyes-Morales, H., Chavez-Soto, M.A., Martinez-Garcia Mdel, C., Soto-Gonzalez, Y., Doubova, S.V., 2002. Intestinal antispasmodic effect of a phytodrug of Psidium guajava folia in the treatment of acute diarrheic disease. Journal of Ethnopharmacology 83, 19-24.
17. Maruyama, Y., Matsuda, H., Matsuda, R., Kubo, M., Hatano, T., Okuda, T., 1985. Study on Psidium guajava L. (I). Anti-diabetic effect and effective components of the leaf of Psidium guajava L. (Part I). Shoyakugaku Zasshi 39, 261-269.
18. Meckes, M., Calzada, F., Tortoriello, J., Gonzalez, J.L., Martinez, M., 1996. Terpenoids isolated from Psidium guajava hexane extract with depressant activity on central nervous system. Phytotherapy Research 10, 600-603.
19. Morales, M.A., Tortoriello, J., Meckes, M., Paz, D., Lozoya, X., 1994. Calcium-antagonist effect of quercetin and its relation with spasmolytic properties of Psidium guajava L. Archives of Medical Research 25, 17-21.
20. Saltiel, A.R., Kahn, C.R., 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
21. Tanaka, T., Ishida, N., Ishimatsu, M., Nonaka, G., Nishioka, I., 1992. Tannins and related compounds. CXVI. Six new complex tannins, guajavins, psidinins and psiguavin from the bark of Psidium guajava L. Chemical and Pharmaceutical Bulletin 40, 2092-2098.
22. Tonks, N.K., 2003. PTP1B: From the sidelines to the front lines! FEBS Letters 546, 140-148.
23. van Huijsduijnen, R.H., Bombrun, A., Swinnen, D., 2002. Selecting protein tyrosine phosphatases as drug targets. Drug Discovery Today 7, 1013-1019.
24. Zhang, B., Salituro, G., Szalkowski, D., Li, Z., Zhang, Y., Royo, I., Vilella, D., Diez, M.T., Pelaez, F., Ruby, C., Kendall, R.L., Mao, X., Griffin, P., Calaycay, J., Zierath, J.R., Heck, J.V., Smith, R.G., Moller, D.E., 1999. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284, 974-977.